---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-029166"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T09:54:58.514914+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical acquires Evoqua concentrates, raises guidance, expects Q4 profitability

## Summary
- Q2 2023 net loss $3.3M ($0.18/sh) vs $5.0M loss ($0.43/sh) in Q2 2022; net sales $18.1M vs $18.7M prior year.
- Acquired Evoqua concentrates business for $12.2M; Evoqua generated $18M annual revenue and $3.3M annual EBITDA.
- Increased 2023 net sales guidance to $82-86M (from $78-82M) and gross profit guidance to $8-10M (from $7-9M).
- Expects to achieve profitability from operations in Q4 2023 and going forward.
- Pro forma cash $16.2M after $13.8M warrant exercise and acquisition funding.

## SEC filing metadata
- accession: 0001628280-23-029166
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828023029166/0001628280-23-029166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828023029166/rmti-20230814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-029166
- JSON: https://secwatch.observer/filing/0001628280-23-029166.json
- Plain text: https://secwatch.observer/filing/0001628280-23-029166.txt

## Key facts
- Earnings Releases
  ROCKWELL MEDICAL, INC. updated its the three and six months ended June 30, 2023 guidance (raised).
  - Period: the three and six months ended June 30, 2023
  - Guidance: raised
  - Result: reported results
  source text: On August 14, 2023, Rockwell Medical, Inc. issued a press release and earnings presentation announcing its financial results for the quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828023029166/0001628280-23-029166-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.